Mona Landin-Olsson
101 – 110 of 217
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Early insulin treatment in latent autoimmune diabetes in adults (LADA) did not improve residual beta cell function or metabolic control
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.391-391(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term consequences on annual earnings of the onset of type I diabetes in young adults. Longitudinal analysis of annual data 1990-2005 for persons born 1949-1970
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.443-443(
- Contribution to journal › Published meeting abstract
-
Mark
Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta-cell autoimmunity and individuals with lesser or no beta-cell autoimmunity
(
- Contribution to journal › Article
-
Mark
Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.
(
- Contribution to journal › Article
-
Mark
Common variants in or around the JAZF1, CDKN2A/2B, CDKAL1 and WFS1 genes discriminate between autoimmune and non-autoimmune diabetes
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.117-117(
- Contribution to journal › Published meeting abstract
-
Mark
Pregnancies in prediabetic women
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.467-468(
- Contribution to journal › Published meeting abstract
-
Mark
Risk Conferred by HLA-DR and DQ for Type 1 Diabetes in 0-35-Year Age Group in Sweden
2008) 9th International Congress of the Immunology-of-Diabeties-Society/American-Diabeties-Association-Research Symposium 1150. p.106-111(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Effects of the DPP-4 Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects with Impaired Glucose Tolerance
(
- Contribution to journal › Article
-
Mark
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
(
- Contribution to journal › Article